101861-59-0

Basic information

• Product Name: 3,5-dibromo-quinoline
• Synonyms: 3,5-dibromo-quinoline;EOS-61483
• CAS NO: 101861-59-0
• Molecular Formula: C9H5Br2N
• Molecular Weight: 287
• Mol File: 101861-59-0.mol
• Article Data: 13

Chemical Properties

• Melting Point: 86℃
• Boiling Point: 333.054 °C at 760 mmHg
• Flash Point: 155.226 °C
• Appearance: /
• Density: 1.924 g/cm³
• CAS DataBase Reference: 3,5-dibromo-quinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-dibromo-quinoline(101861-59-0)
• EPA Substance Registry System: 3,5-dibromo-quinoline(101861-59-0)

Safety Data

• Hazardous Substances Data: 101861-59-0(Hazardous Substances Data)

Usage

General Description

3,5-dibromoquinoline, also known as 3,5-Dibromo-1H-quinoline, is a chemical compound with the molecular formula C9H5Br2N. It is a yellow crystalline solid with a melting point of 49-52°C and is soluble in organic solvents such as ethanol and acetone. 3,5-dibromoquinoline is used as a building block in the synthesis of pharmaceuticals, agrochemicals, and dyes. It has also been studied for its potential use in organic light-emitting diodes (OLEDs) and as an antifungal agent. The compound is known to be harmful if swallowed or inhaled and may cause irritation to the skin and eyes upon contact. As such, proper safety measures should be followed when handling 3,5-dibromoquinoline.

Upstream product

• 116632-57-6 3-bromoquinolin-5-amine 
• 116632-25-8 3,5-dibromo-[6]quinolylamine 
• 5332-24-1 3-bromoquinoline 
• 116632-33-8 3-bromo-5-nitroquinoline 

Downstream Products

• 776296-12-9 5-bromo-3-methoxyquinoline 
• 881656-52-6 3-methoxy-quinoline-5-carbaldehyde 

Relevant articles and documents

Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity

There is an urgent need for new antibacterial drugs that are effective against infections caused by multidrug-resistant pathogens. Novel nonfluoroquinolone inhibitors of bacterial type II topoisomerases (DNA gyrase and topoisomerase IV) have the potential

CYCLOHEXYL OR PIPERIDINYL CARBOXAMIDE ANTIBIOTIC DERIVATIVES

The invention relates to antibiotic cyclohexyl or piperidinyl carboximide derivatives of formula (I) wherein R1 represents hydrogen, halogen, (C1-C4)alkyl, (C1-C4)alkoxy, cyano or COOR2, R2 being (C1-C4)alkyl;one or two of U, V, W and X represent(s) N and the remaining represent each CH, or, in the case of X, may also represent CRX, RX being a halogen atom;either B represents N and A represents CH2CH2 or CH(OR3)CH2, or B represents CH or C(OR4) and A represents OCH2, CH2CH(OR5), CH(OR6)CH2, CH(OR7)CH(OR8), CH═CH or CH2CH2;each of R3, R4, R5, R6, R7, and R8 represents independently hydrogen, SO3H, PO3H2, CH2OPO3H2 or COR9, R9 being either CH2CH2COOH or such that R9—COOH is naturally occurring amino acid or dimethylaminoglycine;and to salts of such compounds of formula (I).

CYCLOHEXYL OR PIPERIDINYL CARBOXAMIDE ANTIBIOTIC DERIVATIVES

The invention relates to antibiotic cyclohexyl or piperidinyl carboxamide derivatives of formula (I) wherein R1 represents hydrogen, halogen, (C1-C4)alkyl, (C1-C4)alkoxy, cyano or COOR2, R2 being (C1-C4)alkyl; one or two of U, V, W and X represent(s) N and the remaining represent each CH, or, in the case of X, may also represent CRx, Rx being a halogen atom; either B represents N and A represents CH2CH2 or CH(OR3)CH2, or B represents CH or C(OR4) and A represents OCH2, CH2CH(OR5), CH(OR6)CH2, CH(OR7)CH(OR8), CH=CH or CH2CH2; each of R3, R4, R5, R6, R7 and R8 represents independently hydrogen, SO3H, PO3H2, CH2OPO3H2 or COR9, R9 being either CH2CH2COOH or such that R9-COOH is a naturally occurring amino acid or dimethylaminoglycine; and to salts of such compounds of formula (I).